Breaking News

Coherus BioSciences Appoints Global Quality SVP

June 9, 2014

Anicetti brings 30+ years of quality and regulatory experience

Vince R. Anicetti has been appointed senior vice president of Global Quality at Coherus BioSciences, Inc. Mr. Anicetti has more than 30 years of experience in quality and regulatory affairs at biopharma companies.
He joins the company from Boehringer-Ingelheim's CA facility, where he served as executive director of Quality, responsible for on-site Regulatory Chemistry, Manufacturing, and Control. Mr. Anicetti also spent 30 years with Genentech and held senior leadership roles in Quality, Regulatory Affairs and Project Portfolio Management, including vice president of Biologics Quality for Genentech and Roche Biologics manufacturing sites around the world.
"Vince's breadth and depth of experience will be critical to delivering to patients high-quality biosimilars with robust consistency," said Denny Lanfear, president and chief executive officer of Coherus. "We are thrilled to welcome Vince to the Coherus team as we advance global development and commercialization strategies across our portfolio."

Related Compliance:

blog comments powered by Disqus
  • The Changing Biopharma Risk Landscape

    The Changing Biopharma Risk Landscape

    June 13, 2016
    Highlights biopharma industry's growth drivers and new approaches for mitigating risk

  • API Sourcing Trends

    Kristin Brooks, Contract Pharma||April 11, 2016
    Drug product complexities, quality and regulatory hurdles drive market shift

  • U.S. Pharma Market Trends

    Kristin Brooks, Contract Pharma||April 8, 2016
    CPhI Report sees return of generic and API manufacturing to U.S. market